GenOx Transportation's Partnership with ESMART Has Proven to Strengthen Fleet Safety and Prevent Incidents
Industrial gas carrier shares results from its 2024 partnership with ESMART, highlighting reduced safety events, improved driver performance, and enhanced fleet security.
INDIANAPOLIS, April 1, 2025 /PRNewswire/ -- Since partnering with ESMART in 2024, GenOx Transportation, Inc. a specialized hazmat carrier serving the industrial gas industry, has experienced a dramatic improvement in fleet safety. By deploying ESMART's advanced Dynamic Speed Management system across its company fleet, GenOx has effectively reduced safety-related incidents, optimized driver coaching, and eliminated speeding violations.
"In our first year, ESMART's technology has helped us achieve measurable improvements in safety," said Chris McCarty, Vice President of Safety at GenOx Transportation. "Since implementing the system, we have had zero speeding citations or CSA violations in the units we have installed. In addition to eliminating speeding events, it has greatly reduced critical safety incidents, including preventing a rollover accident and significantly cutting down on dashcam alerts, for example, following too closely and unsafe lane changes. This has allowed our safety team to focus their time more efficiently, reducing the hours spent reviewing and coaching drivers on avoidable incidents."
As a specialized hauler of compressed and liquefied industrial gases—including Nitrogen, Oxygen, Argon, Carbon Dioxide, Hydrogen, Helium, CNG and LNG—safety remains at the core of GenOx's operations. Beyond speed management, the company is also leveraging ESMART's remote vehicle immobilization feature to prevent unauthorized vehicle use and enhance security measures.
"Our partnership with GenOx demonstrates the power of proactive fleet safety management," said Joe Thell, Sr. Vice President at ESMART. "Their results speak volumes—not only have they eliminated speeding violations, but they have also drastically reduced other risky driving behaviors. We are proud to support their commitment to keeping their fleet and the public safe."
ESMART's Dynamic Speed Management system utilizes GPS-based technology to monitor asset locations in real time and automatically adjust vehicle speeds to stay within predefined safe limits. The system seamlessly integrates with each truck's ECU, enabling fleets to enforce speed-controlled geofences, receive real-time verbal notifications, and ensure consistent speed limit compliance for safer operations.
About GenOx Transportation
Founded in 2001 and headquartered in Deer Park, Texas, GenOx Transportation specializes in hauling compressed and liquefied industrial gas products. With a fleet of specialized trailers and a commitment to safety, GenOx serves a critical role in transporting essential materials for the industrial gas industry. Learn more at www.genoxtransportation.com.
About ESMART
Indianapolis and Montreal-based E-SMART provides Dynamic Speed Management solutions to the transportation industry that reduce the risk and liability from speed violations and speed-related crashes. Fleets deploying E-SMART see improved CSA scores and decreased fuel consumption. In addition to its industry-leading Dynamic Speed Management solution, E-SMART is transforming fleet safety with features such as Low Bridge Collision Prevention, Speed Controlled Geofence Zones and Remote Vehicle Immobilization. For more information, please visit www.esmartcontrol.com.
Media Contact
Callie Myerscmyers@esmartcontrol.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/genox-transportations-partnership-with-esmart-has-proven-to-strengthen-fleet-safety-and-prevent-incidents-302416219.html
SOURCE ESMART
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Verge
18 minutes ago
- The Verge
Meta cracks down on nudify apps after being exposed
Meta is suing a company that advertised generative AI apps on its social media platforms that enable users to 'nudify' people without their consent. The lawsuit against Joy Timeline comes after hundreds of ads for the digital undressing apps were discovered on Meta's Facebook, Messenger, Instagram, and Threads platforms by a CBS News investigation published last week. 'This legal action underscores both the seriousness with which we take this abuse and our commitment to doing all we can to protect our community from it,' Meta said. 'We'll continue to take the necessary steps – which could include legal action – against those who abuse our platforms like this.' Meta's lawsuit specifically aims to prevent Hong Kong-based Joy Timeline from listing its ads for CrushAI nudify apps across its social media platforms, after the company made 'multiple attempts… to circumvent Meta's ad review process.' The legal action comes on the heels of a recently published CBS News investigation that found hundreds of ads for nudify apps across Meta's platforms. Meta told CBS at the time that it has since removed a number of these ads, deleted the accounts running them, and blocked the URLS associated with the nude deepfake apps, but said it's becoming harder to enforce its policies as exploitative generative AI apps find new ways to evade detection. CBS's report said that ads for AI deepfake nude tools could still be found on Instagram after Meta removed ads for apps that had been flagged by the investigation. Many of the ads discovered by CBS targeted men located in the US, UK, and European Union between the ages of 18 and 65. Aside from violating Meta's platform safety and moderation policies, apps that digitally 'undress' people without their consent — overwhelmingly advertised to use against women and female celebrities — are driving an increase in blackmail and 'sextortion' schemes, and frequently find their way into the hands of children. 404 Media published a similar investigation in April 2024 after discovering tools for creating nonconsensual AI deepfakes advertised on Instagram, with Apple and Google later removing apps that were flagged in the report from their respective app marketplaces. San Francisco launched its own lawsuit against 16 of the most frequently visited AI 'undressing' deepfake websites in August 2024.
Yahoo
22 minutes ago
- Yahoo
Nvidia (NVDA) to Host Virtual Annual Shareholder Meeting on June 25
Nvidia (NVDA, Financials) said Wednesday it will conduct its annual shareholder meeting virtually on June 25, with voting and live Q&A available via a secure online portal for registered stockholders. Warning! GuruFocus has detected 4 Warning Signs with NVDA. The Santa Clara-based semiconductor company, which has surged to a $3.49 trillion market valuation, said the proxy materials for the meeting were filed with the U.S. Securities and Exchange Commission on May 13. A recording of the session will remain accessible through June 2026. The meeting comes as Nvidia continues to expand its role in AI infrastructure globally. This month, the company unveiled plans to build an industrial AI cloud platform in Germany and named Micron Technology the first supplier for its new memory solution, SOCAMM, designed for AI server workloads. Nvidia also recently partnered with Novo Nordisk to use AI in drug discovery and showcased video compression tools for autonomous vehicles at its GTC conference in Paris. The company's Gefion supercomputer and GPU stack are being leveraged for breakthroughs across biotech, robotics, and high-performance computing. Nvidia stock closed down 0.75% on the day of the announcement. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
22 minutes ago
- Yahoo
Vaccine maker BioNTech to acquire fellow German pharma firm CureVac
BioNTech, one of the first companies worldwide to develop an effective coronavirus vaccine, is looking to acquire its German pharmaceutical rival CureVac, the firm said on Thursday. BioNTech, which is based in the south-western city of Mainz, is planning to purchase all CureVac shares in a billion-dollar transaction to expand its expertise in the field of mRNA-based cancer therapies, it said. As per the agreement, each CureVac share is to be sold for around $5.46, which would correspond to a valuation of the Tübingen-based company of approximately $1.25 billion. The completion of the acquisition is subject to regulatory approvals and is expected to close by the end of 2025, BioNTech said, with CureVac shareholders to hold between 4% and 6% of BioNTech as a result. Both firms, which are listed on New York's Nasdaq exchange, made headlines during the coronavirus pandemic when they joined the race to develop an effective vaccine against the virus. While CureVac failed to achieve a breakthrough, the mRNA-based vaccination developed by BioNTech in less than a year was widely used to curb the spread of the virus and brought massive profits for the firm. BioNTech now focuses on cancer immunotherapies and aims to submit its first application for approval in the United States by the end of this year for a type of next-generation chemotherapy for uterine cancer. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
